Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability (Nature Neuroscience, (2018), 21, 9, (1161-1170), 10.1038/s41593-018-0206-1)

The 23andMe Research Team, The Substance Use Disorders Working Group of the Psychiatric Genomics Consortium, International Cannabis Consortium

Research output: Contribution to JournalComment / Letter to the editorAcademic

78 Downloads (Pure)

Abstract

Several occurrences of the word ‘schizophrenia’ have been re-worded as ‘liability to schizophrenia’ or ‘schizophrenia risk’, including in the title, which should have been “GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability,” as well as in Supplementary Figures 1–10 and Supplementary Tables 7–10, to more accurately reflect the findings of the work.

Original languageEnglish
Pages (from-to)1196
Number of pages1
JournalNature Neuroscience
Volume22
Issue number7
Early online date5 Jun 2019
DOIs
Publication statusPublished - 1 Jul 2019

Bibliographical note

Correction to: Nature Neuroscience https://www.nature.com/articles/s41593-018-0206-1, published online 27 August 2018

Fingerprint Dive into the research topics of 'Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability (Nature Neuroscience, (2018), 21, 9, (1161-1170), 10.1038/s41593-018-0206-1)'. Together they form a unique fingerprint.

Cite this